全文获取类型
收费全文 | 88978篇 |
免费 | 5812篇 |
国内免费 | 2023篇 |
专业分类
耳鼻咽喉 | 474篇 |
儿科学 | 2037篇 |
妇产科学 | 738篇 |
基础医学 | 9013篇 |
口腔科学 | 1103篇 |
临床医学 | 9347篇 |
内科学 | 12453篇 |
皮肤病学 | 408篇 |
神经病学 | 8826篇 |
特种医学 | 3890篇 |
外国民族医学 | 2篇 |
外科学 | 7172篇 |
综合类 | 14680篇 |
现状与发展 | 6篇 |
预防医学 | 11057篇 |
眼科学 | 697篇 |
药学 | 9283篇 |
119篇 | |
中国医学 | 2856篇 |
肿瘤学 | 2652篇 |
出版年
2024年 | 91篇 |
2023年 | 1218篇 |
2022年 | 2037篇 |
2021年 | 3254篇 |
2020年 | 3232篇 |
2019年 | 2532篇 |
2018年 | 2508篇 |
2017年 | 2509篇 |
2016年 | 2783篇 |
2015年 | 2804篇 |
2014年 | 5931篇 |
2013年 | 6133篇 |
2012年 | 5627篇 |
2011年 | 6044篇 |
2010年 | 4774篇 |
2009年 | 4608篇 |
2008年 | 4743篇 |
2007年 | 4596篇 |
2006年 | 4129篇 |
2005年 | 3521篇 |
2004年 | 2836篇 |
2003年 | 2445篇 |
2002年 | 1897篇 |
2001年 | 1743篇 |
2000年 | 1433篇 |
1999年 | 1214篇 |
1998年 | 1076篇 |
1997年 | 1025篇 |
1996年 | 811篇 |
1995年 | 918篇 |
1994年 | 877篇 |
1993年 | 732篇 |
1992年 | 682篇 |
1991年 | 643篇 |
1990年 | 550篇 |
1989年 | 479篇 |
1988年 | 494篇 |
1987年 | 467篇 |
1986年 | 405篇 |
1985年 | 547篇 |
1984年 | 466篇 |
1983年 | 268篇 |
1982年 | 335篇 |
1981年 | 288篇 |
1980年 | 264篇 |
1979年 | 188篇 |
1978年 | 170篇 |
1977年 | 153篇 |
1976年 | 107篇 |
1974年 | 56篇 |
排序方式: 共有10000条查询结果,搜索用时 218 毫秒
1.
《Saudi Pharmaceutical Journal》2022,30(6):669-678
BackgroundIschemia reperfusion (I/R) play an imperative role in the expansion of cardiovascular disease. Sinomenine (SM) has been exhibited to possess antioxidant, anticancer, anti-inflammatory, antiviral and anticarcinogenic properties. The aim of the study was scrutinized the cardioprotective effect of SM against I/R injury in rat.MethodsRat were randomly divided into normal control (NC), I/R control and I/R + SM (5, 10 and 20 mg/kg), respectively. Ventricular arrhythmias, body weight and heart weight were estimated. Antioxidant, inflammatory cytokines, inflammatory mediators and plasmin system indicator were accessed.ResultsPre-treated SM group rats exhibited the reduction in the duration and incidence of ventricular fibrillation, ventricular ectopic beat (VEB) and ventricular tachycardia along with suppression of arrhythmia score during the ischemia (30 and 120 min). SM treated rats significantly (P < 0.001) altered the level of antioxidant parameters. SM treatment significantly (P < 0.001) repressed the level of creatine kinase MB (CK-MB), creatine kinase (CK) and troponin I (Tnl). SM treated rats significantly (P < 0.001) repressed the tissue factor (TF), thromboxane B2 (TXB2), plasminogen activator inhibitor 1 (PAI-1) and plasma fibrinogen (Fbg) and inflammatory cytokines and inflammatory mediators.ConclusionOur result clearly indicated that SM plays anti-arrhythmia effect in I/R injury in the rats via alteration of oxidative stress and inflammatory reaction. 相似文献
2.
3.
《Revista portuguesa de cardiologia》2022,41(9):783-789
Amiodarone is the most potent antiarrhythmic drug available and is commonly prescribed to treat and prevent not only life-threatening ventricular arrhythmias but also atrial fibrillation (AF). The latest European Society of Cardiology AF guidelines state that amiodarone is recommended for long-term rhythm control in all AF patients but that other antiarrhythmic drugs should be considered first whenever possible, due to its extracardiac toxicity. In patients without significant or with only minimal structural heart disease, amiodarone is not listed as a possibility in their therapeutic scheme. Still, amiodarone is widely and liberally used, and is the most prescribed antiarrhythmic drug for patients with AF despite its high toxicity profile. Non-cardiovascular death was more frequent with amiodarone treatment than with a rate control strategy in AFFIRM, while meta-analyses suggest an association between amiodarone use in patients without structural heart disease and increased non-cardiovascular mortality. Severe or even fatal outcomes due to amiodarone may occur years after treatment initiation and are often not acknowledged by the prescribing physician, who may no longer be following the patient. The lack of widely accepted diagnostic criteria and symptom definitions may lead to underestimation of the incidence of severe side effects and of its toxicity. Unlike the underestimated risk of toxicity with amiodarone, severe complications associated with catheter ablation are usually directly ascribed to the treatment even by non-medical personnel, possibly resulting in overestimation of risks. This brief review will address the issue of amiodarone overuse and the frequent underestimation of its toxicity, while suggesting scenarios in which its use is entirely reasonable, and compare it with catheter ablation. 相似文献
4.
5.
6.
《台湾医志》2022,121(9):1864-1871
7.
《Transfusion Clinique et Biologique》2022,29(3):269-272
A delayed haemolytic transfusion reaction (DHTR) encompasses a positive direct antiglobulin test (DAT) developed anytime between 24 hours to 28 days after cessation of transfusion, a positive eluate or a newly identified alloantibody in the plasma or serum along with features of haemolysis in the patient. Routinely, it is expected that with the transfusion of one unit of packed red cells in a patient of average height and weight, the haemoglobin level and hematocrit increase by 1 g/dL and 3% respectively. However, in a patient with DHTR, an inadequate rise of post-transfusion haemoglobin (< 1 g/dL) or rapid fall in haemoglobin back to pre-transfusion levels is observed. Kidd antibodies are particularly known to cause DHTR, maybe alone or in unison with other antibodies. Detection of these alloantibodies is consequential in providing good transfusion support to these patients. These events may be difficult to detect as they may present as varied clinical features or immunological nuisances. In this case series, we have presented three cases of DHTR with special emphasis on their clinical presentations, immunohaematological evaluations, laboratory parameters and the role of proper transfusion support in these patients to avoid further complications. 相似文献
8.
9.
10.